(2025)
Ergosterol-depleted clinical isolates of Nakaseomyces glabratus can develop multi-drug resistance without apparent fitness and virulence defects.
bioRxiv ,
2025.08.28.672802.
Oliver Kurzai
National Reference Center for Invasive Fungal Infections · Head Fungal Septomics · Head +49 931 31-46161 oliver.kurzai@uni-wuerzburg.deCurriculum vitae
Main Research Areas
- Infection biology of human pathogenic fungi (especially Candida albicans)
- Infection biology of Neisseria meningitidis
Professional Career
| Since 2017 | Chair of Medical Microbiology and Mycology, Institute for Hygiene and Microbiology, Julius Maximilians University Würzburg and head of the research group Fungal Septomics at Leibniz Institute for Natural Product Research and Infection Biology – Hans-Knöll-Institute Jena |
| 2009-2016 | Professor (W2) for Fungal Septomics, Friedrich-Schiller-University Jena |
| 2008 | Habilitation in medical microbiology, University Würzburg |
| 2006 | Medical specialist in microbiology, virology and infection epidemiology (Bayerische Landesärztekammer) |
| 2003 | Head of a working group, Institut für Hygiene und Mikrobiologie, University Würzburg |
| 2001-2002 | Doctor in practical training (AiP), Institut für Hygiene und Mikrobiologie, University Würzburg |
| 2002 | Dr. med., “summa cum laude” University Würzburg |
| 2001 | Staatsexamen (state examination) in human medicine, University Würzburg |
Awards · Appointments · Scientific Activities
| Since 2014 | Head of the Nationales Referenzzentrums für invasive Pilzinfektionen (NRZMyk) |
| Since 2013 | Board member of the Integriertes Forschungs- und Behandlungszentrum “Center for Sepsis Control and Care” (CSCC) at the University Hospital Jena |
| Since 2012 | Scientific Manager of the consortium “InfectControl 2020 – New Antiinfection Strategies – Science • Society • Economy” within the BMBF-Programme “Zwanzig 20 – Partnership for Innovation” (Head: Prof. A. Brakhage) |
| Since 2012 | Editor-in-chief, Medical Mycology Case Reports, member (ex officio) of the executive board of the International Society for Human & Animal Mycology (ISHAM) |
| Since 2011 | Elected note taker at the Deutschsprachige Mykologische Gesellschaft DMykG |
| 2015-2016 | Speaker of the ZIK Septomics |
| 2011-2013 | Editor, Journal of Basic Microbiology |
| 2009 | Hans-Rieth-poster prize from the Deutschsprachige Mykologische Gesellschaft (DMykG) |
| 2008 | Award from the Deutsche Gesellschaft für Hygiene und Mikrobiologie |
| 2003 | Science award from the Unterfränkische Gedenkjahrstiftung |
| 2003 | Dissertation award from the medical faculty of the University Würzburg |
| 2002 | Becton-Dickinson PhD award from the Deutsche Gesellschaft für Hygiene und Mikrobiologie |
Publications
(2025)
Catastrophic cerebral infarctions in a pediatric patient with acute lymphoblastic Leukemia Due to Mucorales Infection.
J Fungi (Basel) 11(9),
618.
(2025)
Culture-positive COVID-19-associated pulmonary aspergillosis (CAPA) in Germany.
Int J Med Microbiol 321,
151676.
(2025)
How to interpret MICs of amphotericin B, echinocandins and flucytosine against Candida auris (Candidozyma auris) according to the newly established European Committee for Antimicrobial Susceptibility Testing (EUCAST) breakpoints.
Clin Microbiol Infect
[Epub ahead of print] (Review)
(2025)
Genomic reconstruction of an azole-resistant Candida parapsilosis outbreak and the creation of a multilocus sequence typing scheme: a retrospective observational and genomic epidemiology study.
Lancet Microbe 6(1),
100949.
(2025)
Global guideline for the diagnosis and management of candidiasis: an initiative of the ECMM in cooperation with ISHAM and ASM.
Lancet Infect Dis 25(5),
e280-e293.
(Review)
(2025)
In vitro activity of novel antifungals, natamycin, and terbinafine against Fusarium.
Antimicrob Agents Chemotherapy 69(6),
e01913-24.
(2025)
Population structure in a fungal human pathogen is potentially linked to pathogenicity.
Nat Commun 16(1),
7594.
(2025)
Unveiling immune interference: how the dendritic cell response to co-infection with Aspergillus fumigatus is modulated by human cytomegalovirus and its virokine CMVIL-10.
mBio
[Epub ahead of print]
(2025)
Dipsticks and point-of-care microscopy in urinary tract infections in primary care: Results of the MicUTI pilot cluster randomised controlled trial.
PLoS One 20(10),
e0332390.